LIDOCAINE HYDROCHLORIDE

Post-LOE

lidocaine hydrochloride

R-Pharm US

ANDATOPICALSOLUTION

Approved

Mar 2014

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

LIDOCAINE HYDROCHLORIDE (lidocaine hydrochloride) by R-Pharm US is mechanism of action lidocaine hcl stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. Approved for regional anesthesia, analgesia for surgery, dental and 4 more indications. First approved in 2014.

Drug data last refreshed 18h ago

Mechanism of Action

Mechanism of Action Lidocaine HCl stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action.

Indications (7)

regional anesthesia analgesia for surgery dental

Worked on LIDOCAINE HYDROCHLORIDE at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

LIDOCAINE HYDROCHLORIDE

Mechanism of Action

Indications (7)

Clinical Trials (1)